1.0Tris Pharmarich600338<blockquote class="wp-embedded-content" data-secret="e6WhNfwD5t"><a href="/tris-pharma-announces-the-fda-acceptance-of-nda-for-dyanavel-xr/">Tris Pharma Announces the FDA Acceptance of NDA for Dyanavel™ XR</a></blockquote&dafabet live dealer gamegt;<iframe sandbox="allow-scripts" security="restricted" src="/tris-pharma-announces-the-fda-acceptance-of-nda-for-dyanavel-xr/embed/#?secret=e6WhNfwD5t" width="600" height="338" title="“Tris Pharma Announces the FDA Acceptance of NDA for Dyanavel™ XR” — Tris Pharma" data-secret="e6WhNfwD5t" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ dafabet online betting!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll(dafabet sports betting'iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.dafabet online bettingvalue,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener(dafabet live casino"DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},dafabet live casino!1)))}(window,document); </script> MONMOUTH JUNCTION, N.J., May 21, 2015; - Tris Pharma, Inc. ("Tris") announced that U.S. Food and Drug Administration ("FDA") has accepted for review its...